
|Videos|May 26, 2022
Dose Reductions and Treatment Breaks on Lenvatinib Therapy
Author(s)Tom Powles, MBBS, MRCP, MD, Brian Shimkus, MD
Dr Brian Shimkus describes how he doses lenvatinib for renal cell carcinoma treatment.
Advertisement
Episodes in this series

Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on CancerNetwork
1
Zavabresib Earns FDA Orphan Drug Designation in Myelofibrosis
2
New CAR T-Cell Therapy Earns FDA Breakthrough Status in T-Cell Malignancies
3
Median OS Not Yet Reached With New Immunotherapy Combo in 2L Glioblastoma
4
Data Show Potentially Higher Disease Burden Among Male NDMM Population
5














































